147 related articles for article (PubMed ID: 14743190)
1. Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease.
Sbano P; Rubegni P; De Aloe GB; Guidi S; Fimiani M
Bone Marrow Transplant; 2004 Apr; 33(8):869-70. PubMed ID: 14743190
[No Abstract] [Full Text] [Related]
2. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis in graft-versus-host disease.
Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
[TBL] [Abstract][Full Text] [Related]
4. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
5. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
6. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
7. Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
Perotti C; Del Fante C; Viarengo G; Salvaneschi L
Transfusion; 2004 Oct; 44(10):1531-2. PubMed ID: 15383028
[No Abstract] [Full Text] [Related]
8. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
9. B-cell involvement in chronic graft-versus-host disease.
Kapur R; Ebeling S; Hagenbeek A
Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
[TBL] [Abstract][Full Text] [Related]
10. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases].
D'incan M; Kanold J; Halle P; De Lumley L; Souteyrand P; Deméocq F
Ann Dermatol Venereol; 2000 Feb; 127(2):166-70. PubMed ID: 10739974
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
[No Abstract] [Full Text] [Related]
12. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
13. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
14. Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus.
Schlaak M; Treudler R; Colsman A; Al-Ali H; Simon JC
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):112-3. PubMed ID: 18181987
[No Abstract] [Full Text] [Related]
15. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
17. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
[TBL] [Abstract][Full Text] [Related]
18. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sparing effect of extracorporeal photopheresis in the treatment of graft-vs-host disease.
Coyle TS; Nam TK; Camouse MM; Stevens SR; Baron ED
Arch Dermatol; 2004 Jun; 140(6):763-4. PubMed ID: 15210480
[No Abstract] [Full Text] [Related]
20. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
